QT Imaging Secures UAE Distribution Deal for Breast Imaging Tech

  • QT Imaging signed an exclusive distribution agreement with Al Naghi Medical for UAE territory.
  • Minimum order quantities start at 7 scanners in 2026, rising to 20 by 2028, totaling $24M+ in revenue.
  • QTI Breast Acoustic CT scanner offers non-invasive 3D imaging without compression or radiation.
  • QTI Cloud Platform provides SaaS-based imaging intelligence and AI/ML advancements.
  • Breast cancer accounts for 25% of cancer cases in UAE, with younger median age of diagnosis.

QT Imaging's deal with Al Naghi Medical marks its entry into a high-need market where breast cancer is prevalent and diagnosed earlier than in Western countries. The agreement underscores the strategic importance of non-invasive imaging technologies in regions with specific healthcare challenges. With a projected $24M+ in revenue from this partnership, QT Imaging is positioning itself as a key player in transforming breast health through innovative imaging solutions.

Market Penetration
Whether QT Imaging can sustain growth in the UAE given the younger median age of breast cancer diagnosis.
Technology Adoption
The pace at which hospitals and clinics in the UAE adopt the QTI Breast Acoustic CT scanner and QTI Cloud Platform.
Regulatory Compliance
How QT Imaging navigates regulatory matters in the UAE to ensure smooth deployment of its technology.